Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03124472
Other study ID # 169
Secondary ID
Status Recruiting
Phase N/A
First received April 19, 2017
Last updated January 30, 2018
Start date June 1, 2017
Est. completion date June 2018

Study information

Verified date January 2018
Source Cairo University
Contact Ahmed Maged, MD
Phone 01005227404
Email prof.ahmedmaged@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pfannenstiel incision of skin and opening of the anterior abdominal wall in layers.

- The loose peritoneum of the lower uterine segment is dissected downwards to mobilize the urinary bladder and expose the lower uterine segment.

- Uterine artery ligation was performed by grasping the broad ligament with thumb anterior and the index finger lifting the base below the site uterine incision; the uterine artery was singly ligated with No. 1 vicryl suture. Myometrium was included so that uterine vessels are not damaged.

- Cresenteric lower uterine segment incision was performed as usual. Higher incisions were performed in cases where the traditional incision was expected to be directly through the placenta Delivery of the baby and placenta.

- Closure of the uterine incision in 2 layers with N0. 1 vicryl suture.

- Closure of the anterior abdominal wall in layers


Description:

Pfannenstiel incision of skin and opening of the anterior abdominal wall in layers.

- The loose peritoneum of the lower uterine segment is dissected downwards to mobilize the urinary bladder and expose the lower uterine segment.

- Uterine artery ligation was performed by grasping the broad ligament with thumb anterior and the index finger lifting the base below the site uterine incision; the uterine artery was singly ligated with No. 1 vicryl suture. Myometrium was included so that uterine vessels are not damaged.

- Cresenteric lower uterine segment incision was performed as usual. Higher incisions were performed in cases where the traditional incision was expected to be directly through the placenta Delivery of the baby and placenta.

- Closure of the uterine incision in 2 layers with N0. 1 vicryl suture.

- Closure of the anterior abdominal wall in layers In the control group, lower segment caesarean section is without uterine artery ligation


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date June 2018
Est. primary completion date May 2018
Accepts healthy volunteers No
Gender Female
Age group 19 Years to 40 Years
Eligibility Inclusion Criteria:

- patients diagnosed with placenta praevia antenatally

- plan is elective caesarean section

- Gestational age >34 weeks

Exclusion Criteria:

- Fetal distress

- medical disorders as hypertension or Diabetes Mellitus

- Coagulation defects.

- Emergency Cesarean section

- women with antepartum hemorrhage

- patients with marked ahdesions or those with non possible uterine artery ligation

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
uterine artery ligation
Uterine artery ligation was performed by grasping the broad ligament with thumb anterior and the index finger lifting the base below the site uterine incision; the uterine artery was singly ligated with No. 1 vicryl suture. Myometrium was included so that uterine vessels are not damaged
Lower segment Cesarean section
Pfannenstiel incision of skin and opening of the anterior abdominal wall in layers. - The loose peritoneum of the lower uterine segment is dissected downwards to mobilize the urinary bladder and expose the lower uterine segment. Cresenteric lower uterine segment incision was performed as usual. Higher incisions were performed in cases where the traditional incision was expected to be directly through the placenta Delivery of the baby and placenta. Closure of the uterine incision in 2 layers with N0. 1 vicryl suture. Closure of the anterior abdominal wall in layers

Locations

Country Name City State
Egypt Kasr Alainy medical school Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Decrease in Hemoglabin level 24 hours after Cesarean
See also
  Status Clinical Trial Phase
Recruiting NCT04518163 - Bakri Balloon Plus Tranexamic Acid During Cesarean Delivery for Placenta Previa N/A
Recruiting NCT04518150 - Combined Bilateral Uterine Artery Ligation and Bakri Balloon During Cesarean Section N/A
Recruiting NCT03638024 - Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .
Terminated NCT01996345 - Vaginal Pessary Versus Expectant Management for Placenta Previa N/A
Recruiting NCT04609527 - Management of Placenta Accreta Spectrum Phase 2/Phase 3
Completed NCT03321435 - The Placenta Previa and Fetal Weight N/A
Completed NCT03431116 - Low Implanted Second Trimester Placenta and Placenta Previa N/A
Enrolling by invitation NCT05529381 - Anxiety and Depressive Symptoms in Placenta Previa / Accreta
Completed NCT04264234 - Management Of Placenta Previa Cases And Determination Of Hospitalization Criteria N/A
Completed NCT05340205 - Blood Loss During Cesarean Delivery in Placenta Previa Patients Phase 4
Completed NCT03570723 - Glove-loaded Foley's Catheter Tamponade for Cesarean Section for Placenta Previa N/A
Completed NCT05283122 - Mostafa Maged Technique to Control and Prevent the Post-Partum Bleeding From the Lower Uterine Segment in Placenta Previa Cases N/A
Withdrawn NCT01442207 - Cerclage for Prevention on Preterm Birth in Women With Placenta Previa Phase 3
Not yet recruiting NCT03451136 - Cervical Length in Cases of Placenta Previa N/A
Completed NCT02966197 - Efficacy of Prophylactic Internal Iliac Artery Balloon Catheterization in the Management of Placenta Previa and Accreta N/A
Recruiting NCT02590484 - The Cervix as a Natural Tamponade in Postpartum Hemorrhage Caused by Placenta Previa and Placenta Previa Accreta N/A
Recruiting NCT05802251 - Sonographic Parameters and Risk of Antepartum Hemorrhage in Asymptomatic Women With Placenta Previa: A Cohort Study
Completed NCT03542552 - Nifedipine Versus Magnesium Sulfate for Prevention of Preterm Labor in Symptomatic Placenta Previa Phase 3
Recruiting NCT03633175 - Progesterone in Patients With Placenta Previa Phase 2
Not yet recruiting NCT03208842 - Relation of Implantation Site to Placental Site in Presence or Absence of Cesarean Section Scar N/A